PHP
TMDX icon

Parkman Healthcare Partners’s Transmedics TMDX Stock Holding History

Parkman Healthcare Partners’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-45,174
Closed -$5.5M – 113
2025
Q4 		$5.5M Buy
+45,174
New +$5.67M 0.52% 58
2023
Q1 		– Sell
-55,351
Closed -$3.42M – 95
2022
Q4 		$3.42M Buy
55,351
+12,993
+31% +$691K 0.91% 42
2022
Q3 		$1.77M Buy
+42,358
New +$1.84M 0.5% 62

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parkman Healthcare Partners's TMDX Position: Q1 2026 in Review

Parkman Healthcare Partners sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 45,174 shares — an estimated $5.5M sold.

Parkman Healthcare Partners first reported a position in TMDX in Q3 2022 and held it in 3 quarters. The position peaked at $5.5M in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Parkman Healthcare Partners reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
  • Parkman Healthcare Partners sold 45,174 Transmedics shares in Q1 2026, an estimated $5.5M.
  • Parkman Healthcare Partners first reported a position in Transmedics in Q3 2022 and held it in 3 quarters.
  • Parkman Healthcare Partners's Transmedics position peaked at $5.5M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.